The concern I have is that the market is cautious of new plays right now, regardless of NPV numbers printed in scoping studies.
Im glad the HVY team were able to get to the scoping study, after all it is a significant milestone in the development of the company. I am tapering my expectations about the impact this will have on the share price.
The markets in general are facing strong head winds and I'm not sure a number on paper will be enough to elevate and sustain the price.
Ann: Trading Halt, page-14
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
